Invitro International

Invitro International Liabilities

The The Liabilities of Invitro International (IVRO) as of Oct 15, 2026 is 348,179.00 USD. In the previous year, The Liabilities was 381,170.00 USD — a change of -8.66% (lower).

Liabilities

348,179.00USD

YoY

-8.66%

Last updated:

In 2025, Invitro International's total liabilities amounted to 348,179.00 USD, a -8.66% difference from the 381,170.00 USD total liabilities in the previous year.

The Invitro International Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2017
74,110.00 USD
Jan 1, 2019
154,072.00 USD
Jan 1, 2020
212,163.00 USD
Jan 1, 2021
201,610.00 USD
Jan 1, 2022
68,237.00 USD
Jan 1, 2023
78,990.00 USD
Jan 1, 2024
381,170.00 USD
Jan 1, 2025
348,179.00 USD
The Invitro International Liabilities history
YEARLiabilitiesYoY
348,179.00USD-8.66%
381,170.00USD+382.55%
78,990.00USD+15.76%
68,237.00USD-66.15%
201,610.00USD-4.97%
212,163.00USD+37.70%
154,072.00USD+107.90%
74,110.00USD—
Access this data via the Eulerpool API

Invitro International Stock analysis

What does Invitro International do? Invitro International is a leading company in the development of cell and tissue cultures as well as test systems for the pharmaceutical, cosmetic, and biotechnology industry. The company was founded in 1982 by Dr. George K. J. Uehara, a renowned scientist and specialist in the field of cell culture technology. His aim was to create a reliable alternative to animal testing to meet the industry's need for safe and effective test systems. Invitro International offers a wide range of products, including cell cultures and tissue samples derived from human or animal tissue. These are of the highest quality and are manufactured under strict quality controls. The tissue cultures are obtained from living organs and are ideal for the development of new drugs and cosmetics, as well as for studying the effects of environmental toxins and chemicals. Another focus of Invitro International is the development of test systems tailored to the needs of customers. These can include in vitro tests on cell and tissue cultures, as well as molecular analysis and screening methods. The company is divided into various industries and sectors, including pharmaceutical research, toxicology, cosmetics industry, biotechnology, and environmental research. Each of these sectors is supervised by specialized scientists and experts who have in-depth knowledge and experience in their respective fields. Invitro International places great emphasis on environmentally friendly and ethical standards in the development of new test systems and products. The company is also involved in various initiatives to promote alternatives to animal testing and actively advocates for the protection and welfare of animals. One of Invitro International's most well-known products is the Eye Irritation Test System (EITS), which is widely used in the cosmetics industry. It is a reliable in vitro test that determines the eye irritation potentials of new products based on human tissue. Invitro International has become a leading company in the field of cell culture technology and is now known worldwide for its high-quality products and services. The company takes pride in offering its customers safe, effective, and environmentally friendly test systems and is committed to continuing to develop innovative solutions to meet the industry's requirements. Invitro International is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Invitro International's Liabilities

Invitro International's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Invitro International's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Invitro International's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Invitro International's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Invitro International’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Invitro International stock

The Liabilities of Invitro International is 348,179.00 USD in 2025.

The Liabilities of Invitro International changed from 381,170.00 USD to 348,179.00 USD, representing a -8.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Invitro International since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Invitro International historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Invitro International

All Key Metrics — Invitro International